Galapagos GLPG Stock
Galapagos Price Chart
Galapagos GLPG Financial and Trading Overview
| Galapagos stock price | 33.03 USD |
| Previous Close | 41.63 USD |
| Open | 42.05 USD |
| Bid | 0 USD x 1100 |
| Ask | 0 USD x 1400 |
| Day's Range | 41.69 - 42.51 USD |
| 52 Week Range | 36.17 - 58.04 USD |
| Volume | 131.53K USD |
| Avg. Volume | 222.39K USD |
| Market Cap | 2.81B USD |
| Beta (5Y Monthly) | 0.05977 |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | -7.95 USD |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | 47.99 USD |
GLPG Valuation Measures
| Enterprise Value | 51.83B USD |
| Trailing P/E | N/A |
| Forward P/E | -17.260162 |
| PEG Ratio (5 yr expected) | -26.72 |
| Price/Sales (ttm) | 5.1332397 |
| Price/Book (mrq) | 21.955633 |
| Enterprise Value/Revenue | 94.613 |
| Enterprise Value/EBITDA | -284.232 |
Trading Information
Galapagos Stock Price History
| Beta (5Y Monthly) | 0.05977 |
| 52-Week Change | -21.18% |
| S&P500 52-Week Change | 20.43% |
| 52 Week High | 58.04 USD |
| 52 Week Low | 36.17 USD |
| 50-Day Moving Average | 40.87 USD |
| 200-Day Moving Average | 42 USD |
GLPG Share Statistics
| Avg. Volume (3 month) | 222.39K USD |
| Avg. Daily Volume (10-Days) | 159.85K USD |
| Shares Outstanding | 65.9M |
| Float | 884.97M |
| Short Ratio | 4.44 |
| % Held by Insiders | 0% |
| % Held by Institutions | 20.34% |
| Shares Short | 1.33M |
| Short % of Float | N/A |
| Short % of Shares Outstanding | 2.02% |
Dividends & Splits
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0% |
| 5 Year Average Dividend Yield | N/A |
| Payout Ratio | 0 |
| Last Split Factor |
Financial Highlights
Fiscal Year
| Fiscal Year Ends | December 31, 2022 |
| Most Recent Quarter (mrq) | March 31, 2023 |
| Next Fiscal Year End | December 31, 2023 |
Profitability
| Profit Margin | -33.12% |
| Operating Margin (ttm) | -36.091% |
| Gross Margin | 7.86% |
| EBITDA Margin | -33.28% |
Management Effectiveness
| Return on Assets (ttm) | -2.53% |
| Return on Equity (ttm) | -6.96% |
Income Statement
| Revenue (ttm) | 547.8M USD |
| Revenue Per Share (ttm) | 0.42 USD |
| Quarterly Revenue Growth (yoy) | 31.19% |
| Gross Profit (ttm) | 4.82M USD |
| EBITDA | -182347008 USD |
| Net Income Avi to Common (ttm) | -181474000 USD |
| Diluted EPS (ttm) | -2.9 |
| Quarterly Earnings Growth (yoy) | N/A |
Balance Sheet
| Total Cash (mrq) | 3.99B USD |
| Total Cash Per Share (mrq) | 3.01 USD |
| Total Debt (mrq) | 16M USD |
| Total Debt/Equity (mrq) | 0.62 USD |
| Current Ratio (mrq) | 7.947 |
| Book Value Per Share (mrq) | 1.9339 |
Cash Flow Statement
| Operating Cash Flow (ttm) | -533443008 USD |
| Levered Free Cash Flow (ttm) | -137709632 USD |
Profile of Galapagos
| Country | United States |
| State | N/A |
| City | Mechelen |
| Address | Generaal De Wittelaan L11 A3 |
| ZIP | 2800 |
| Phone | 32 1 534 29 00 |
| Website | https://www.glpg.com |
| Industry | Biotechnology |
| Sector(s) | Healthcare |
| Full Time Employees | 1338 |
Galapagos NV, an integrated biopharmaceutical company, engages in the discovery, development, and commercialization of?various medicines for high unmet medical need. Its pipeline products include filgotinib, a JAK1 inhibitor that is in various phases of clinical trials for the treatment of rheumatoid arthritis, Crohn's disease, ulcerative colitis, ankylosing spondylitis, psoriatic arthritis, and uveitis. The company's pipeline products also comprise GLPG3667 that has completed Phase 1b trial; and GLPG5101 and GLPG5201, CD19 CAR-T product candidate manufactures at point-of-care, that is in Phase I/II in relapsed/refractory non-Hodgkin lymphoma and chronic lymphocytic leukemia. The company has collaboration agreements with Gilead Sciences, Inc.; AbbVie S.à r.l.; and Novartis Pharma AG. Galapagos NV was incorporated in 1999 and is headquartered in Mechelen, Belgium.
Q&A For Galapagos Stock
What is a current GLPG stock price?
Galapagos GLPG stock price today per share is 33.03 USD.
How to purchase Galapagos stock?
You can buy GLPG shares on the Tech Market Large exchange. Contact your financial advisor to select a broker.
What is the ticker symbol for Galapagos?
The stock symbol or ticker of Galapagos is GLPG.
Which industry does the Galapagos company belong to?
The Galapagos industry is Biotechnology.
How many shares does Galapagos have in circulation?
The max supply of Galapagos shares is 65.9M.
What is Galapagos Price to Earnings Ratio (PE Ratio)?
Galapagos PE Ratio is now.
What was Galapagos earnings per share over the trailing 12 months (TTM)?
Galapagos EPS is -7.95 USD over the trailing 12 months.
Which sector does the Galapagos company belong to?
The Galapagos sector is Healthcare.
Galapagos GLPG included in indexes
| Name Name | Price Price |
24h% 7d chart 24h% & 7d |
VOL Volume | 24h low | 24h high | Volume |
|---|
| Name Name | Price Price |
24h% 7d chart 24h% & 7d |
VOL Volume | 24h low | 24h high | Volume | |
|---|---|---|---|---|---|---|---|
| {{ item.name }} {{ item.symbol }} | {{ item.price }} {{ item.price_usd }} |
{{ item.change_pct }}
|
{{ item.volume }} {{ item.volume_usd }} | {{ item.low }} {{ item.low_usd }} | {{ item.high }} {{ item.high_usd }} | {{ item.components_count }} - | {{ item.volume }} {{ item.volume_usd }} |
| US Tech Composite IXIC | 23593.1 USD — |
-0.09
|
4.42B USD — | 23567.86 USD — | 23665.15 USD — | — - | 4.42B USD — |
| US Tech Composite Total Return XCMP | 29011.05 USD — |
-0.09
|
— — | 28980.01 USD — | 29099.65 USD — | — - | — — |
| Stlmt ID US Tech Biotechnology NBX | 3995.9 USD — |
-4.37
|
— — | 4555.41 USD — | 4917.8 USD — | — - | — — |
| US Tech Global Select Market Com NQGS | 11560.74 USD — |
-0.05
|
— — | 11548.2 USD — | 11595.66 USD — | — - | — — |
| US Tech Biotechnology NBI | 5809.25 USD — |
-0.59
|
— — | 5792.54 USD — | 5835.34 USD — | — - | — — |
| US Tech Health Care IXHC | 1206.13 USD — |
-0.49
|
— — | 1203.49 USD — | 1210.54 USD — | — - | — — |
- {{ link.label }} {{link}}